Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Pulmonary alveolar microlithiasis: A report on two familial cases in Morocco].

Revue des maladies respiratoires·2023
Same author

[Recurrent skin and lung lesions].

La Revue de medecine interne·2021
Same author

[A case of bronchopulmonary sequestration].

Revue des maladies respiratoires·2019
Same author

Allopurinol-induced Drug Reactions with Eosinophilia and Systemic Symptoms Syndrome with Interstitial Nephritis.

Indian journal of nephrology·2019
Same author

[Red eye of unusual cause].

La Revue de medecine interne·2017
Same author

Refeeding syndrome: a forgotten and potentially lethal entity.

Medecine et sante tropicales·2016
Same journal

Real-time documentation of acute pre-retinal hemorrhage in central retinal vein occlusion.

Journal francais d'ophtalmologie·2026
Same journal

Incidental detection of benign lobular inner nuclear layer proliferations (BLIPs) in a young adult.

Journal francais d'ophtalmologie·2026
Same journal

Combined autonomic and cranial neuropathy following radiofrequency ablation for trigeminal neuralgia.

Journal francais d'ophtalmologie·2026
Same journal

[Point-of-care biomarkers of ocular surface disease: Current approaches and future perspectives].

Journal francais d'ophtalmologie·2026
Same journal

Granulomatous reaction after hybrid hyaluronic acid-calcium hydroxyapatite filler injection in supratarsal hollow correction.

Journal francais d'ophtalmologie·2026
Same journal

Sequential dexamethasone and fluocinolone acetonide intravitreal implants to treat macular edema in non-infectious uveitis.

Journal francais d'ophtalmologie·2026
See all related articles

Related Experiment Video

Updated: May 18, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

[Ocular involvement in polyarteritis nodosa: two cases].

A Abouzahir1, Y Bennouk, M El Qatni

  • 1Service de médecine interne B, hôpital militaire d'instruction Mohammed V, 10000 Riad, Rabat, Maroc. a_abouzahir@yahoo.fr

Journal Francais D'Ophtalmologie
|September 18, 2012
PubMed
Summary
This summary is machine-generated.

Ocular involvement in Polyarteritis Nodosa (PAN) is rare but serious. Prompt diagnosis and immunosuppressive treatment are crucial for favorable outcomes in patients with PAN and vision loss.

More Related Videos

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Related Experiment Videos

Last Updated: May 18, 2026

Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
06:15

Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia

Published on: August 9, 2024

Area of Science:

  • Ophthalmology
  • Rheumatology
  • Systemic Vasculitis

Background:

  • Polyarteritis Nodosa (PAN) is a systemic vasculitis characterized by diverse clinical presentations.
  • Ocular manifestations in PAN are infrequent but can lead to significant visual impairment.

Observation:

  • Two cases of PAN with ocular involvement are presented: one with pigment epithelial detachment and another with branch vein occlusion and serous retinal detachments.
  • Both patients experienced decreased visual acuity due to their ocular conditions.

Findings:

  • Ocular involvement in PAN, affecting retinal and choroidal arteries, occurs in 10-20% of cases.
  • Fluorescein angiography is the diagnostic standard, revealing characteristic choriocapillaris ischemia.
  • Prompt treatment with immunosuppressants and corticosteroids led to favorable outcomes in both reported cases.

Implications:

  • Early recognition of ocular symptoms in PAN is vital for timely intervention.
  • Aggressive immunosuppressive therapy is indicated for severe ocular manifestations of PAN to preserve vision.
  • This highlights the importance of a multidisciplinary approach in managing PAN with ocular complications.